These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 34037477

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Ribotypes and antimicrobial susceptibility profiles of clinical Clostridioides difficile isolates: A multicenter, laboratory-based surveillance in Taiwan, 2019-2021.
    Tsai CS, Lu PL, Lu MC, Hsieh TC, Chen WT, Wang JT, Ko WC.
    J Microbiol Immunol Infect; 2024 Apr; 57(2):320-327. PubMed ID: 38135646
    [Abstract] [Full Text] [Related]

  • 3. Five-year Pan-European, longitudinal surveillance of Clostridium difficile ribotype prevalence and antimicrobial resistance: the extended ClosER study.
    Freeman J, Vernon J, Pilling S, Morris K, Nicolson S, Shearman S, Clark E, Palacios-Fabrega JA, Wilcox M, Pan-European Longitudinal Surveillance of Antibiotic Resistance among Prevalent Clostridium difficile Ribotypes’ Study Group.
    Eur J Clin Microbiol Infect Dis; 2020 Jan; 39(1):169-177. PubMed ID: 31811507
    [Abstract] [Full Text] [Related]

  • 4. Antimicrobial resistance progression in the United Kingdom: A temporal comparison of Clostridioides difficile antimicrobial susceptibilities.
    Jon J V, Mark H W, Jane F.
    Anaerobe; 2021 Aug; 70():102385. PubMed ID: 34048922
    [Abstract] [Full Text] [Related]

  • 5. Fluoroquinolone resistance and Clostridium difficile, Germany.
    Zaiss NH, Witte W, Nübel U.
    Emerg Infect Dis; 2010 Apr; 16(4):675-7. PubMed ID: 20350385
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Antimicrobial susceptibility pattern of Clostridium difficile and its relation to PCR ribotypes in a Swedish university hospital.
    Aspevall O, Lundberg A, Burman LG, Akerlund T, Svenungsson B.
    Antimicrob Agents Chemother; 2006 May; 50(5):1890-2. PubMed ID: 16641471
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. High in vitro activity of fidaxomicin against Clostridium difficile isolates from a university teaching hospital in China.
    Cheng JW, Yang QW, Xiao M, Yu SY, Zhou ML, Kudinha T, Kong F, Liao JW, Xu YC.
    J Microbiol Immunol Infect; 2018 Jun; 51(3):411-416. PubMed ID: 28693926
    [Abstract] [Full Text] [Related]

  • 13. Detection of Plasmid-Mediated Resistance to Metronidazole in Clostridioides difficile from River Water.
    Cizek A, Masarikova M, Mares J, Brajerova M, Krutova M.
    Microbiol Spectr; 2022 Aug 31; 10(4):e0080622. PubMed ID: 35950844
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Fidaxomicin versus metronidazole, vancomycin and their combination for initial episode, first recurrence and severe Clostridioides difficile infection - An observational cohort study.
    Polivkova S, Krutova M, Capek V, Sykorova B, Benes J.
    Int J Infect Dis; 2021 Feb 31; 103():226-233. PubMed ID: 33188906
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. U.S.-Based National Surveillance for Fidaxomicin Susceptibility of Clostridioides difficile-Associated Diarrheal Isolates from 2013 to 2016.
    Thorpe CM, McDermott LA, Tran MK, Chang J, Jenkins SG, Goldstein EJC, Patel R, Forbes BA, Johnson S, Gerding DN, Snydman DR.
    Antimicrob Agents Chemother; 2019 Jul 31; 63(7):. PubMed ID: 31085514
    [Abstract] [Full Text] [Related]

  • 18. Molecular epidemiology and antimicrobial resistance of Clostridioides difficile in Germany, 2014-2019.
    Abdrabou AMM, Ul Habib Bajwa Z, Halfmann A, Mellmann A, Nimmesgern A, Margardt L, Bischoff M, von Müller L, Gärtner B, Berger FK.
    Int J Med Microbiol; 2021 May 31; 311(4):151507. PubMed ID: 33915347
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Circulation of Highly Drug-Resistant Clostridium difficile Ribotypes 027 and 001 in Two Tertiary-Care Hospitals in Mexico.
    Martínez-Meléndez A, Tijerina-Rodríguez L, Morfin-Otero R, Camacho-Ortíz A, Villarreal-Treviño L, Sánchez-Alanís H, Rodríguez-Noriega E, Baines SD, Flores-Treviño S, Maldonado-Garza HJ, Garza-González E.
    Microb Drug Resist; 2018 May 31; 24(4):386-392. PubMed ID: 29485939
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.